| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $20.62 | $10,307.75 | -0.7% | |
| Jul 30, 2020 | CVSI Cv Sciences, Inc. | Mona Michael Joseph Jr | 10% Owner | Sell | 108,535 | $0.58 | $63,126.15 | -21.0% | |
| Jul 28, 2020 | CANN Trees Corp (colorado) | Hershey Adam | Director, 10% Owner | Buy | 2,046,196 | $0.40 | $814,999.87 | +37.3% | |
| Jul 28, 2020 | SNY Sanofi | Sanofi | 10% Owner | Buy | 81,250 | $16.00 | $1,300,000.00 | +18.5% | |
| Jul 28, 2020 | JNJ Johnson & Johnson | McEvoy Ashley | EVP, Ww Chair, Medical Devices | Sell | 29,000 | $147.47 | $4,276,630.00 | -57.2% | |
| Jul 23, 2020 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 3,000 | $16.02 | $48,051.30 | -0.5% | |
| Jul 21, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | EVP Corp Admin Center | Sell | 10,164 | $21.14 | $214,883.67 | -9.9% | |
| Jul 17, 2020 | MRK Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gi Pub Policy | Sell | 36,285 | $80.00 | $2,902,976.29 | -33.7% | |
| Jul 17, 2020 | DVAX Dynavax Technologies Corp | Janssen Robert71 | Senior Vice President | Sell | 50,000 | $11.09 | $554,500.00 | -28.2% | |
| Jul 16, 2020 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 350,000 | $7.62 | $2,667,571.80 | -2.8% | |
| Jul 15, 2020 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 22,125 | $16.01 | $354,254.44 | -3.5% | |
| Jul 15, 2020 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 12,000 | $56.88 | $682,560.00 | -6.0% | |
| Jul 13, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Hudson Frederick M. | Director | Sell | 920 | $24.44 | $22,484.80 | -4.9% | |
| Jul 13, 2020 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 1,429 | $17.01 | $24,307.29 | -3.0% | |
| Jul 12, 2020 | HROW Harrow, Inc. | Opaleye Management Inc.60 | - | Buy | 112,700 | $4.97 | $560,132.67 | +1.3% | |
| Jul 9, 2020 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 1,657 | $136.02 | $225,385.80 | -6.0% | |
| Jul 9, 2020 | BMY Bristol Myers Squibb Co | Celgene Corp /de/ | 10% Owner | Sell | 2,241 | $102.28 | $229,209.48 | - | |
| Jul 9, 2020 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 11,000 | $170.00 | $1,870,000.00 | -37.1% | |
| Jul 9, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 12,961 | $169.69 | $2,199,392.14 | - | |
| Jul 9, 2020 | ANIK Anika Therapeutics, Inc. | Loerop James | EVP Business Development | Sell | 1,244 | $35.15 | $43,726.60 | -41.5% | |
| Jul 9, 2020 | HROW Harrow, Inc. | Opaleye Management Inc.60 | - | Buy | 136,300 | $5.02 | $683,703.95 | +1.7% | |
| Jul 7, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $167.29 | $35,131,799.23 | - | |
| Jul 6, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 13,656 | $22.00 | $300,404.69 | -11.9% | |
| Jul 6, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $166.99 | $34,232,085.89 | - | |
| Jul 6, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 41,854 | $0.29 | $12,092.52 | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.